Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Oncogene, Hoechst Marion Roussel AG deal

ONCS and Hoechst Marion Roussel AG signed their 1996 agreement

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE